Catalyst Event

ABL Bio Inc (298380) · Other

From KRX Bio Technology Transfer Index (KBIOTT)

5/11/2026, 12:00:00 AM

OtherSentiment: Neutral

Scheduled to present clinical data for its 'Grabody-T' platform, including results for Ragistomic (ABL503) and Givastomic (ABL111), at the PEGS Boston conference from May 11-15, 2026 scheduled.

Korean Translation

2026년 5월 11일부터 15일까지 열리는 PEGS 보스턴 학회에서 '그랩바디-T' 플랫폼의 임상 데이터(라지스토믹 ABL503, 기바스토믹 ABL111 등)를 발표할 예정임.

Related Recent Events

View Full Timeline